New reverse-logistics capacity in Illinois

The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

The Drug Supply Chain Security Act was a major coverage area for Pharma Commerce in 2024.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

As a result, the provider increases its involvement in the country’s pharma sector.

The 430,000 square-foot finished production facility will house multiple product types within the rare disease sector, including hemophilia.